Paragon 28 Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
446
- Stock Symbol
-
7GQ
- Investments
-
3
- Share Price
-
$13.10
- (As of Thursday Closing)
Paragon 28 General Information
Description
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of revenue from the United States.
Contact Information
Website
www.paragon28.comCorporate Office
- 14445 Grasslands Drive
- Englewood, CO 80112
- United States
Corporate Office
- 14445 Grasslands Drive
- Englewood, CO 80112
- United States
Paragon 28 Stock Performance
As of 17-Apr-2025, Paragon 28’s stock price is $13.10. Its current market cap is $1.1B with 84.2M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $13.10 | $12.81 | $4.70 - $13.11 | $1.1B | 84.2M | -$0.66 |
Paragon 28 Financials Summary
As of 31-Dec-2024, Paragon 28 has a trailing 12-month revenue of $256M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 936,305 | 936,305 | 1,035,955 | 1,460,797 |
| Revenue | 256,182 | 256,182 | 216,389 | 181,383 |
| EBITDA | (23,403) | (23,403) | (36,614) | (47,856) |
| Net Income | (54,639) | (54,639) | (57,534) | (65,649) |
| Total Assets | 290,717 | 290,717 | 332,683 | 255,786 |
| Total Debt | 110,686 | 110,686 | 110,439 | 42,910 |
Paragon 28 Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Paragon 28 Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Paragon 28 Comparisons
Industry
Financing
Details
Paragon 28 Competitors (18)
One of Paragon 28’s 18 competitors is Treace Medical Concepts, a Formerly VC-backed company based in Ponte Vedra Beach, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Treace Medical Concepts | Formerly VC-backed | Ponte Vedra Beach, FL | ||||
| Wright Medical Group | Formerly PE-Backed | Middlesex, United Kingdom | ||||
| CrossRoads Extremity Systems | Formerly PE-Backed | Memphis, TN | ||||
| Zimmer Biomet Holdings | Corporation | Warsaw, IN | ||||
| MicroPort Scientific | Formerly VC-backed | Shanghai, China |
Paragon 28 Patents
Paragon 28 Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1070084-S1 | Bone cut guide | Active | 05-Jun-2023 | ||
| US-D1076092-S1 | Span bone plate | Active | 01-Feb-2023 | ||
| US-D1076090-S1 | Straddle bone plate | Active | 01-Feb-2023 | ||
| US-D1076091-S1 | Straddle bone plate | Active | 01-Feb-2023 | ||
| AU-2023354404-A1 | Implants, instrumentation, and surgical methods for ankle arthroplasty procedures | Pending | 29-Sep-2022 | A61B17/1682 |
Paragon 28 Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Paragon 28 Investments & Acquisitions (3)
Paragon 28’s most recent deal was a Merger/Acquisition with Disior for . The deal was made on 10-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Disior | 10-Jan-2022 | Merger/Acquisition | Decision/Risk Analysis | ||
| Additive Orthopaedics | 01-Jun-2021 | Merger/Acquisition | Therapeutic Devices | ||
| Additive Orthopaedics (3D-Printed Talus Spacer and Surgical Planning Application in New Jersey) | 01-Jun-2021 | Corporate Asset Purchase | Buildings and Property |
Paragon 28 ESG
Risk Overview
Risk Rating
Updated July, 06, 2023
30.59 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,631
Rank
Percentile
Healthcare
Industry
of 563
Rank
Percentile
Medical Devices
Subindustry
of 196
Rank
Percentile
Paragon 28 Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Disior | Helsinki, Finland | 2016 | |
| Additive Orthopaedics | Little Silver, NJ | 2015 |
Paragon 28 FAQs
-
When was Paragon 28 founded?
Paragon 28 was founded in 2010.
-
Where is Paragon 28 headquartered?
Paragon 28 is headquartered in Englewood, CO.
-
What is the size of Paragon 28?
Paragon 28 has 446 total employees.
-
What industry is Paragon 28 in?
Paragon 28’s primary industry is Surgical Devices.
-
Is Paragon 28 a private or public company?
Paragon 28 is a Public company.
-
What is Paragon 28’s stock symbol?
The ticker symbol for Paragon 28 is 7GQ.
-
What is the current stock price of Paragon 28?
As of 17-Apr-2025 the stock price of Paragon 28 is $13.10.
-
What is the current market cap of Paragon 28?
The current market capitalization of Paragon 28 is $1.1B.
-
What is Paragon 28’s current revenue?
The trailing twelve month revenue for Paragon 28 is $256M.
-
Who are Paragon 28’s competitors?
Treace Medical Concepts, Wright Medical Group, CrossRoads Extremity Systems, Zimmer Biomet Holdings, and MicroPort Scientific are some of the 18 competitors of Paragon 28.
-
What is Paragon 28’s annual earnings per share (EPS)?
Paragon 28’s EPS for 12 months was -$0.66.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
